Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Consolidated Statements of Operations and Comprehensive Loss [Abstract]
Net sales	$ 8,270	$ 8,740
Cost of goods sold	3,146	3,064
Gross profit	5,124	5,676
Operating expenses:
Selling, general and administrative	13,518	13,455
Research and development	2,712	3,209
Total operating expenses	16,230	16,664
Loss from operations	(11,106)	(10,988)
Other income (expense), net
Other income (expense)	10	(80)
Gain on settlement	0	900
Financing expense	(10,553)	(5,607)
Change in fair value of warrant liability	4,133	4,615
Loss before income taxes	(17,516)	(11,160)
Income tax expense	(5)	(5)
Net loss	(17,521)	(11,165)
Deemed dividend attributable to Series J Convertible Preferred Stock	4	541
Net loss attributable to common stockholders	$ (17,517)	$ (10,624)
Basic loss per share (in Dollars per share)	$ (25.39)	$ (353.3)
Diluted loss per share (in Dollars per share)	$ (25.39)	$ (353.3)
Weighted average shares outstanding - basic (in Shares)	690,145	31,601
Weighted average shares outstanding - diluted (in Shares)	690,145	31,601
Other comprehensive loss:
Net loss	$ (17,521)	$ (11,165)
Unrealized foreign currency translation adjustment	55	(16)
Total comprehensive loss	$ (17,466)	$ (11,181)